Bottles for the Pfizer BioNTech COVID-19 vaccine are ready to be prepared before the opening of a mass vaccination site in the Queens borough of New York, February 24, 2021.
Seth Wenig | Pool | Reuters
Pfizer CEO Albert Bourla said Tuesday that his company has ramped up production of its two-shot coronavirus vaccine and will be able to deliver a total of 300 million doses to the U.S. ahead of schedule.
Bourla said Pfizer can deliver 10% more doses to the U.S. by the end of May than it had previously agreed to produce. The company will be able to supply the full 300 million to the U.S. two weeks early, he said.
The announcement came as dozens of states temporarily stopped administering Johnson & Johnson’s single-dose Covid vaccine, following an advisory from the Food and Drug Administration to do so after six women in the U.S. developed a rare blood-clotting disorder that left one woman dead and another in critical condition.
Some states, such as New York, said they will use Pfizer’s vaccine in place of the J&J shot for appointments that had already been scheduled.
President Joe Biden last month set a goal of getting enough Americans vaccinated in time for them to safely gather in small groups for the Fourth of July. He also vowed that every adult in the U.S. will have access to the vaccine by the end of May.
The Biden administration in February said that it had purchased enough vaccine doses from Pfizer and Moderna for both companies to deliver 300 million shots by the end of July. The government’s total purchase from Pfizer came to approximately $6 billion.
This is breaking news. Please check back for updates.